glp 1 for pcos covered by insurance Is glp1 pcos? Rising use of GLP-1 medications

J Nutr 1999

and serotonin norepinephrine reuptake inhibitors (SNRIs) like venlafaxine (Effexor), duloxetine (Cymbalta), and desvenlafaxine (Pristiq) 248,249 Stimulants (ie, a class of drugs usually used to treat attention deficit disorder), such as methylphenidate (Ritalin) and amphetamine-dextroamphetamine (Adderall) 248 Sedatives, such as diazepam (Valium) and triazolam (Halcion) 250 Drugs used to treat cognitive disorders, such as donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne) 251-253 Cold medications, particularly pseudoephedrine (Sudafed) and combination products with pseudoephedrine 248 Glucocorticoids, such as prednisone (Deltasone), dexamethasone (Decadron), and methylprednisolone (Medrol) 254,255 Smoking cessation therapies, such as varenicline (Champix), bupropion (Zyban), and nicotine replacement patches (Nicoderm), lozenges (Nicorette), and gum (Nicorette) 248 Opioid pain relievers, such as morphine (MS-Contin and others), tramadol (Ultram), oxycodone (Oxycontin), hydrocodone/acetaminophen (Vicodin), oxymorphone (Opana), and fentanyl (Duragesic) 248,256 Some asthma medications, eg, theophylline (Elixophyllin and others) and albuterol (Ventolin and others) 257 Some blood pressure-lowering drugs, eg, beta-blockers like atenolol (Tenormin) and metoprolol (Lopressor) 258,259 Although sedatives in the drug class called benzodiazepines, including diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan), and clonazepam (Klonopin), are frequently used to treat insomnia and anxiety, their use can disrupt normal sleep architecture by increasing time in N2 sleep and reducing restorative N3 slow-wave sleep and REM sleep

Chin J Comp Med 2021;31:69-75

The active GLP-1 plasma levels of the diabetic control rats (514 pm) were lower than those for TSGH-treated group (1332 pm) and for HSGH-treated group (737 pm) and the DPP4 activity reduced from 1155 in the diabetic group to 866 and 716 % in the HSGH- and TSGH-treated groups, respectively (Reference Wang, Hsieh and Hung49)

However, our in vitro analysis in MIN6 cells showed that expression of PPAR-, GLP-1R, and GIPR were reduced after 24-h treatments with 1-mM metformin in the presence of 5.5 mM glucose (data not shown)

By the end, you will know exactly which compound aligns with your situation, and you will understand why the answer is not as simple as picking whichever one sounds more impressive on paper